HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hung Huynh Selected Research

2- ((((2- chloroethyl)nitrosoamino)carbonyl)amino)propanamide (SarCNU)

7/2006Xenografts of human hepatocellular carcinoma: a useful model for testing drugs.
12/20042-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hung Huynh Research Topics

Disease

34Neoplasms (Cancer)
10/2021 - 03/2002
28Hepatocellular Carcinoma (Hepatoma)
01/2021 - 03/2002
7Neoplasm Metastasis (Metastasis)
10/2021 - 09/2003
4Retinoblastoma (Glioblastoma, Retinal)
08/2012 - 03/2004
4Liver Neoplasms (Liver Cancer)
03/2010 - 03/2002
3Carcinogenesis
10/2021 - 10/2004
3Hypoxia (Hypoxemia)
11/2020 - 11/2007
3Ascites
07/2008 - 11/2007
3Body Weight (Weight, Body)
12/2004 - 06/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 07/2015
2Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 08/2012
2Stomach Neoplasms (Stomach Cancer)
10/2015 - 09/2009
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
04/2015 - 01/2009
2Carcinoma (Carcinomatosis)
11/2007 - 12/2004
2Prostatic Neoplasms (Prostate Cancer)
05/2004 - 09/2003
2Keloid
04/2003 - 07/2002
1COVID-19
02/2022
1Tics (Tic)
08/2017
1Adenocarcinoma of Lung
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2015
1Tuberous Sclerosis (Bourneville's Disease)
05/2015

Drug/Important Bio-Agent (IBA)

8Sorafenib (BAY 43-9006)FDA Link
01/2021 - 01/2009
8Phosphotransferases (Kinase)IBA
12/2020 - 09/2003
8Proteins (Proteins, Gene)FDA Link
04/2020 - 01/2004
6Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2021 - 10/2008
6AZD 6244IBA
08/2012 - 01/2007
6Sirolimus (Rapamycin)FDA Link
03/2010 - 11/2007
5infigratinibIBA
10/2021 - 01/2019
5Bevacizumab (Avastin)FDA Link
12/2020 - 11/2007
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 08/2003
4TOR Serine-Threonine KinasesIBA
03/2010 - 11/2007
4QuercetinIBA
06/2004 - 09/2003
3Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2021 - 11/2020
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 11/2007
3Pharmaceutical PreparationsIBA
11/2020 - 06/2008
3Vinorelbine (Navelbine)FDA LinkGeneric
11/2020 - 01/2019
3Cyclin B1IBA
03/2012 - 09/2007
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2009 - 11/2007
2roblitinibIBA
10/2021 - 11/2020
2Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2020
2Epithelial Cell Adhesion MoleculeIBA
08/2017 - 08/2013
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 07/2015
2EverolimusFDA Link
05/2015 - 07/2009
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2012 - 03/2012
2Mitogen-Activated Protein KinasesIBA
03/2010 - 08/2003
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2009 - 01/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2008 - 09/2007
2Cyclin D1IBA
11/2007 - 09/2007
2Hormones (Hormone)IBA
10/2007 - 09/2003
22- ((((2- chloroethyl)nitrosoamino)carbonyl)amino)propanamide (SarCNU)IBA
07/2006 - 12/2004
2Antineoplastic Agents (Antineoplastics)IBA
12/2004 - 05/2004
2Messenger RNA (mRNA)IBA
01/2004 - 07/2002
2MitogensIBA
04/2003 - 03/2002
2Insulin-Like Growth Factor Binding Protein 3IBA
04/2003 - 03/2002
1VaccinesIBA
02/2022
1Granzymes (Granzyme)IBA
10/2021
1ribociclibIBA
01/2021
1Angiogenesis InhibitorsIBA
12/2020
1tyrosine receptor (receptor, tyrosine)IBA
01/2020
1SHP099IBA
01/2020
1N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamideIBA
01/2019
1Glycoproteins (Glycoprotein)IBA
08/2017
1UbiquitinIBA
01/2017
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017
1belinostatIBA
01/2017
1SurvivinIBA
01/2017
1sepantroniumIBA
01/2017
1aprutumab ixadotinIBA
11/2016
1auristatinIBA
11/2016
1Immunoconjugates (Immunoconjugate)IBA
11/2016
1RNA (Ribonucleic Acid)IBA
10/2015
1Trastuzumab (Herceptin)FDA Link
10/2015
1regorafenibIBA
10/2015
1RamucirumabIBA
10/2015
1AntibodiesIBA
10/2015
1mirdametinibIBA
10/2015
1saracatinibIBA
10/2015
1Mechanistic Target of Rapamycin Complex 1IBA
05/2015
1trans-sodium crocetinate (crocetin)IBA
05/2015
1Imatinib Mesylate (Gleevec)FDA Link
04/2015
1GadoliniumIBA
04/2014
1Flucytosine (Ancobon)FDA Link
08/2013
13-deazaneplanocinIBA
08/2013
1ApolipoproteinsIBA
08/2013
1Apolipoproteins E (ApoE)IBA
08/2013
1LuciferasesIBA
08/2013
1ProdrugsIBA
08/2013
1Cytosine DeaminaseIBA
08/2013
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
08/2012
1Complement System Proteins (Complement)IBA
08/2012
1GSK 1363089IBA
03/2012
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
03/2012
1Histones (Histone)IBA
03/2012
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2011
1Tyrosine Kinase InhibitorsIBA
03/2010
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
03/2010

Therapy/Procedure

7Therapeutics
11/2020 - 09/2009
4Drug Therapy (Chemotherapy)
01/2019 - 07/2008
1Aftercare (After-Treatment)
01/2021
1Radiotherapy
04/2020